Moreover, in chicken DT40 B lymphoma cells, TRAIP withstands DNA topoisomerase II-induced chromosome breakage, suggesting that TRAIP may be a therapeutic target for DNA damage-induced cancer [176]. This evidence concerns the gene TRAIP and lymphoma.